论文部分内容阅读
行业维持景气度,业绩释放好于预期经营持续向好,资产注入全面推进业绩增长确定,分析师调高盈利预测当前股价:12.32元今日投资个股安全诊断星级:★★★★★08年主要增长情况仁和药业08年的主导产品中妇炎洁收入同比增长17.73%,优卡丹同比增长107%,可立克增长9.6%。胃康
Industry to maintain the boom degree, the release of performance is better than expected Business continued to improve, asset injection Comprehensively promote the performance growth to determine, analysts increase the profit forecast Current stock price: 12.32 yuan investment stocks today, the safety diagnosis Star Rating: ★ ★ ★ ★ ★ 08 major Growth situation Renhe Pharmaceutical’s leading products in 2008 Fu Yan Jie revenue up 17.73%, Yucatan up 107%, can increase 9.6%. Weikang